Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2008

01-02-2008

Genetic counseling for inherited thrombophilias

Author: Elizabeth A. Varga

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2008

Login to get access

Abstract

Genetic testing for inherited thrombophilia, including mutation analysis for factor V Leiden and prothrombin G20210A, is commonly performed. Yet, tests for inherited thrombophilia are frequently ordered inappropriately, and without proper counseling about the risks, benefits and limitations of testing. Genetic counselors are uniquely trained to help people understand and adapt to medical, psychological and familial implications of genetic contributions to disease. In the context of thrombophilia, genetic counselors may serve as a resource to other clinicians to: (a) identify individuals and families at increased risk for inherited thrombophilia, (b) offer and explain testing to patients and families, as appropriate, (c) facilitate patient-focused decision-making and informed consent prior to testing, (d) interpret test results, (e) explain inheritance patterns and discuss implications of thrombophilia for family members and (f) provide education and support resources. This article will provide insight into the training and roles of genetic counselors, review indications for thrombophilia testing, and highlight specific issues related to genetic testing, including genetic discrimination concerns.
Literature
1.
go back to reference Spector EB, Grody WW, Matteson CJ, Palomaki GE, Bellissimo DB, Wolff DJ et al (2005) Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories. Genet Med 7(6):444–453PubMed Spector EB, Grody WW, Matteson CJ, Palomaki GE, Bellissimo DB, Wolff DJ et al (2005) Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories. Genet Med 7(6):444–453PubMed
2.
go back to reference Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA (2001) American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 3(2):139–148PubMed Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA (2001) American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 3(2):139–148PubMed
3.
go back to reference McGlennen RC, Key NS (2002) Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med 126(11):1319–1325PubMed McGlennen RC, Key NS (2002) Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med 126(11):1319–1325PubMed
4.
go back to reference Press RD, Bauer KA, Kujovich JL, Heit JA (2002) Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 126(11):1304–1318PubMed Press RD, Bauer KA, Kujovich JL, Heit JA (2002) Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 126(11):1304–1318PubMed
6.
go back to reference Saukko PM, Richards S, Shepherd MH, Campbell J (2006) Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia. Soc Sci Med 63(7):1947–1959PubMedCrossRef Saukko PM, Richards S, Shepherd MH, Campbell J (2006) Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia. Soc Sci Med 63(7):1947–1959PubMedCrossRef
7.
go back to reference Bank I, Scavenius MP, Buller HR, Middeldorp S (2004) Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thromb Res 113(1):7–12PubMedCrossRef Bank I, Scavenius MP, Buller HR, Middeldorp S (2004) Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thromb Res 113(1):7–12PubMedCrossRef
8.
go back to reference Hellmann EA, Leslie ND, Moll S (2003) Knowledge and educational needs of individuals with the factor V Leiden mutation. J Thromb Haemost 1(11):2335–2339PubMedCrossRef Hellmann EA, Leslie ND, Moll S (2003) Knowledge and educational needs of individuals with the factor V Leiden mutation. J Thromb Haemost 1(11):2335–2339PubMedCrossRef
10.
go back to reference Cosmi B, Legnani C, Bernardi F, Coccheri S, Palareti G (2003) Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception. Arch Intern Med 163(9):1105–1109PubMedCrossRef Cosmi B, Legnani C, Bernardi F, Coccheri S, Palareti G (2003) Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception. Arch Intern Med 163(9):1105–1109PubMedCrossRef
11.
go back to reference Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F (1997) Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives? Thromb Haemost 78(6):1480–1483PubMed Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F (1997) Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives? Thromb Haemost 78(6):1480–1483PubMed
12.
go back to reference Makris M, Rosendaal FR, Preston FE (1997) Familial thrombophilia: genetic risk factors and management. J Intern Med Suppl 740:9–15PubMed Makris M, Rosendaal FR, Preston FE (1997) Familial thrombophilia: genetic risk factors and management. J Intern Med Suppl 740:9–15PubMed
13.
go back to reference Seligsohn U, Zivelin A (1997) Thrombophilia as a multigenic disorder. Thromb Haemost 78(1):297–301PubMed Seligsohn U, Zivelin A (1997) Thrombophilia as a multigenic disorder. Thromb Haemost 78(1):297–301PubMed
14.
go back to reference Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA (2001) American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 3(2):139–148PubMedCrossRef Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA (2001) American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 3(2):139–148PubMedCrossRef
15.
go back to reference Press RD, Bauer KA, Kujovich JL, Heit JA (2002) Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 126(11):1304–1318PubMed Press RD, Bauer KA, Kujovich JL, Heit JA (2002) Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 126(11):1304–1318PubMed
16.
go back to reference Brenner BR, Nowak-Gottl U, Kosch A, Manco-Johnson M, Laposata M (2002) Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children. Arch Pathol Lab Med 126(11):1296–1303PubMed Brenner BR, Nowak-Gottl U, Kosch A, Manco-Johnson M, Laposata M (2002) Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children. Arch Pathol Lab Med 126(11):1296–1303PubMed
17.
go back to reference Laurino MY, Bennett RL, Saraiya DS, Baumeister L, Doyle DL, Leppig K et al (2005) Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors. J Genet Couns 14(3):165–181PubMedCrossRef Laurino MY, Bennett RL, Saraiya DS, Baumeister L, Doyle DL, Leppig K et al (2005) Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors. J Genet Couns 14(3):165–181PubMedCrossRef
18.
go back to reference Wu O, Robertson L, Twaddle S, Lowe GDO, Clark P, Greaves M et al (2006) Screening for thrombophilia in high-risk situations: systemic review and cost-effectiveness analysis. The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 10(11):1–110PubMed Wu O, Robertson L, Twaddle S, Lowe GDO, Clark P, Greaves M et al (2006) Screening for thrombophilia in high-risk situations: systemic review and cost-effectiveness analysis. The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 10(11):1–110PubMed
19.
go back to reference Reich LM, Bower M, Key NS (2003) Role of the geneticist in testing and counseling for inherited thrombophilia. Genet Med 5(3):133–143PubMed Reich LM, Bower M, Key NS (2003) Role of the geneticist in testing and counseling for inherited thrombophilia. Genet Med 5(3):133–143PubMed
20.
go back to reference Varga, EA (2007) Inherited thrombophilias: key points for genetic counseling. J Genet Couns, May 1 [Epub ahead of print] Varga, EA (2007) Inherited thrombophilias: key points for genetic counseling. J Genet Couns, May 1 [Epub ahead of print]
Metadata
Title
Genetic counseling for inherited thrombophilias
Author
Elizabeth A. Varga
Publication date
01-02-2008
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2008
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-007-0056-2

Other articles of this Issue 1/2008

Journal of Thrombosis and Thrombolysis 1/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.